These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37884917)
1. The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity. Shatri H; Purnamandala ; Hidayat R; Sinto R; Widhani A; Putranto R; Purnamasari RD; Ginanjar E; Jasirwan COM BMC Psychiatry; 2023 Oct; 23(1):785. PubMed ID: 37884917 [TBL] [Abstract][Full Text] [Related]
2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H; Ekblom-Kullberg S; Miettinen A Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [TBL] [Abstract][Full Text] [Related]
3. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Ho A; Barr SG; Magder LS; Petri M Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976 [TBL] [Abstract][Full Text] [Related]
4. Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors. Yilmaz-Oner S; Ilhan B; Can M; Alibaz-Oner F; Polat-Korkmaz O; Ozen G; Mumcu G; Kremers HM; Tuglular S; Direskeneli H Z Rheumatol; 2017 Dec; 76(10):913-919. PubMed ID: 27600110 [TBL] [Abstract][Full Text] [Related]
5. Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus. Tay SH; Cheung PP; Mak A Lupus; 2015 Nov; 24(13):1392-9. PubMed ID: 26085594 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity. El-Banna HS; El Khouly RM; Gado SE Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692 [TBL] [Abstract][Full Text] [Related]
9. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic. Nasiri S; Karimifar M; Bonakdar ZS; Salesi M Rheumatol Int; 2010 Nov; 30(12):1605-9. PubMed ID: 19809816 [TBL] [Abstract][Full Text] [Related]
10. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity. Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Macêdo EA; Appenzeller S; Costallat LT Lupus; 2016 Oct; 25(12):1315-27. PubMed ID: 26989166 [TBL] [Abstract][Full Text] [Related]
12. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life. Elefante E; Tani C; Stagnaro C; Signorini V; Lenzi B; Zucchi D; Trentin F; Carli L; Ferro F; Mosca M Front Med (Lausanne); 2022; 9():859840. PubMed ID: 35425779 [TBL] [Abstract][Full Text] [Related]
13. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS. Yang L; Gu B; Wang X; Ren Q; Shen M; Su D Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38305645 [TBL] [Abstract][Full Text] [Related]
14. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821 [TBL] [Abstract][Full Text] [Related]
15. Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS). Macêdo EA; Appenzeller S; Costallat LTL Lupus; 2018 Feb; 27(2):179-189. PubMed ID: 28587586 [TBL] [Abstract][Full Text] [Related]
16. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients. Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892 [TBL] [Abstract][Full Text] [Related]
17. Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity. Ibrahim MRK; Waly NG; Moness H; Ahmed SS; Ibrahem R Mol Biol Rep; 2023 Dec; 50(12):10025-10036. PubMed ID: 37904010 [TBL] [Abstract][Full Text] [Related]
18. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity. Su CC; Shau WY; Wang CR; Chuang CY; Chen CY Lupus; 1997; 6(5):449-54. PubMed ID: 9229364 [TBL] [Abstract][Full Text] [Related]
19. Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies. Narayanan K; Marwaha V; Shanmuganandan K; Shankar S Med J Armed Forces India; 2010 Apr; 66(2):102-7. PubMed ID: 27365721 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus. de Almeida Macêdo E; Appenzeller S; Lavras Costallat LT Rheumatol Int; 2017 Dec; 37(12):1999-2004. PubMed ID: 28940018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]